1. Lack of Effect of Celecoxib on Prostaglandin E2 Concentrations in Nipple Aspirate Fluid from Women at Increased Risk of Breast Cancer
    Edward R. Sauter et al, 2004, Cancer Epidemiology, Biomarkers & Prevention CrossRef
  2. Contribution of non-steroidal anti-inflammatory drugs to breast cancer treatment: In vitro and in vivo studies
    Tiago Ferreira et al, 2024, Veterinary World CrossRef
  3. Neoadjuvant Endocrine Therapy as a Drug Development Strategy
    Matthew J. Ellis, 2004, Clinical Cancer Research CrossRef
  4. Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice
    Susan Lanza-Jacoby et al, 2004, Molecular Cancer Therapeutics CrossRef
  5. Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer
    N.K. Altorki et al, 2003, Journal of Clinical Oncology CrossRef
  6. Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion
    Rebecca S. Y. Wong, 2019, Advances in Pharmacological Sciences CrossRef
  7. Celecoxib Inhibits Vascular Endothelial Growth Factor Expression in and Reduces Angiogenesis and Metastasis of Human Pancreatic Cancer via Suppression of Sp1 Transcription Factor Activity
    Daoyan Wei et al, 2004, Cancer Research CrossRef
  8. Encapsulation of Ibuprofen in CD-MOF and Related Bioavailability Studies
    Karel J. Hartlieb et al, 2017, Molecular Pharmaceutics CrossRef
  9. Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments
    Chau T. Dang et al, 2004, Clinical Cancer Research CrossRef
  10. Cyclooxygenase-2 Expression in Postmastectomy Chest Wall Relapse
    Janet H. Kim et al, 2005, Clinical Cancer Research CrossRef
  11. Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an In vivo Model of Spontaneous Metastatic Breast Cancer
    Gargi D. Basu et al, 2004, Molecular Cancer Research CrossRef
  12. MR Monitoring of Cyclooxygenase-2 Inhibition of Angiogenesis in a Human Breast Cancer Model in Rats
    Laure S. Fournier et al, 2007, Radiology CrossRef
  13. Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer
    Yuqing Sun et al, 2019, Molecular Pharmaceutics CrossRef
  14. COX and cancer
    D. Mazhar et al, 2005, QJM: An International Journal of Medicine CrossRef
  15. Interactions between Prostaglandin E2, Liver Receptor Homologue-1, and Aromatase in Breast Cancer
    Jiong Zhou et al, 2005, Cancer Research CrossRef